These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 24358975)

  • 1. Prevention of bioprosthetic heart valve calcification: strategies and outcomes.
    Bre LP; McCarthy R; Wang W
    Curr Med Chem; 2014; 21(22):2553-64. PubMed ID: 24358975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of calcification in bioprosthetic heart valves: challenges and perspectives.
    Simionescu DT
    Expert Opin Biol Ther; 2004 Dec; 4(12):1971-85. PubMed ID: 15571459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feasibility evaluation of a new pericardial bioprosthesis with dye mediated photo-oxidized bovine pericardial tissue.
    Bianco RW; Phillips R; Mrachek J; Witson J
    J Heart Valve Dis; 1996 May; 5(3):317-22. PubMed ID: 8793684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcification of tissue heart valve substitutes: progress toward understanding and prevention.
    Schoen FJ; Levy RJ
    Ann Thorac Surg; 2005 Mar; 79(3):1072-80. PubMed ID: 15734452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radical polymerization-crosslinking method for improving extracellular matrix stability in bioprosthetic heart valves with reduced potential for calcification and inflammatory response.
    Guo G; Jin L; Jin W; Chen L; Lei Y; Wang Y
    Acta Biomater; 2018 Dec; 82():44-55. PubMed ID: 30326277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased cellular expression of matrix proteins that regulate mineralization is associated with calcification of native human and porcine xenograft bioprosthetic heart valves.
    Srivatsa SS; Harrity PJ; Maercklein PB; Kleppe L; Veinot J; Edwards WD; Johnson CM; Fitzpatrick LA
    J Clin Invest; 1997 Mar; 99(5):996-1009. PubMed ID: 9062358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initiation of mineralization in bioprosthetic heart valves: studies of alkaline phosphatase activity and its inhibition by AlCl3 or FeCl3 preincubations.
    Levy RJ; Schoen FJ; Flowers WB; Staelin ST
    J Biomed Mater Res; 1991 Aug; 25(8):905-35. PubMed ID: 1918108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A synergistic strategy of dual-crosslinking and loading intelligent nanogels for enhancing anti-coagulation, pro-endothelialization and anti-calcification properties in bioprosthetic heart valves.
    Hu M; Shi S; Peng X; Pu X; Yu X
    Acta Biomater; 2023 Nov; 171():466-481. PubMed ID: 37793601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Porcine bioprosthetic valve calcification in bovine left ventricle-aorta shunts: studies of the deposition of vitamin K-dependent proteins.
    Levy RJ; Zenker JA; Bernhard WF
    Ann Thorac Surg; 1983 Aug; 36(2):187-92. PubMed ID: 6603825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiscale multimodal characterization and simulation of structural alterations in failed bioprosthetic heart valves.
    Tsolaki E; Corso P; Zboray R; Avaro J; Appel C; Liebi M; Bertazzo S; Heinisch PP; Carrel T; Obrist D; Herrmann IK
    Acta Biomater; 2023 Oct; 169():138-154. PubMed ID: 37517619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of bioprosthetic heart valve calcification by ethanol preincubation. Efficacy and mechanisms.
    Vyavahare N; Hirsch D; Lerner E; Baskin JZ; Schoen FJ; Bianco R; Kruth HS; Zand R; Levy RJ
    Circulation; 1997 Jan; 95(2):479-88. PubMed ID: 9008467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of anticalcification treatments on bioprosthetic heart valves implanted in sheep.
    Jones M; Eidbo EE; Hilbert SL; Ferrans VJ; Clark RE
    ASAIO Trans; 1988; 34(4):1027-30. PubMed ID: 3219249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In Search of the Ideal Valve: Optimizing Genetic Modifications to Prevent Bioprosthetic Degeneration.
    Smood B; Hara H; Cleveland DC; Cooper DKC
    Ann Thorac Surg; 2019 Aug; 108(2):624-635. PubMed ID: 30836101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of leaflet calcification of bioprosthetic heart valves with diphosphonate injection therapy. Experimental studies of optimal dosages and therapeutic durations.
    Levy RJ; Schoen FJ; Lund SA; Smith MS
    J Thorac Cardiovasc Surg; 1987 Oct; 94(4):551-7. PubMed ID: 3116348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimineralization treatments for bioprosthetic heart valves. Assessment of efficacy and safety.
    Schoen FJ; Levy RJ; Hilbert SL; Bianco RW
    J Thorac Cardiovasc Surg; 1992 Nov; 104(5):1285-8. PubMed ID: 1434707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Surgical pathology analysis of the causes of failure of 48 bioprosthetic heart valves in 40 Chinese cases].
    Duan XJ; Wang HY; Xu JP; Li L; Xu HY; Wang QZ
    Zhonghua Wai Ke Za Zhi; 2016 Sep; 54(9):710-5. PubMed ID: 27587216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The future of bioprosthetic valves.
    Magilligan DJ
    ASAIO Trans; 1988; 34(4):1031-2. PubMed ID: 3219250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Swim bladder as an alternative biomaterial for bioprosthetic valves.
    Li N; Li X; Ma Y; Qiao F; Bai Y; Liu X; Xu Z
    Biomater Sci; 2021 Dec; 9(24):8356-8365. PubMed ID: 34786584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue damage and calcification may be independent mechanisms of bioprosthetic heart valve failure.
    Vesely I; Barber JE; Ratliff NB
    J Heart Valve Dis; 2001 Jul; 10(4):471-7. PubMed ID: 11499593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue heart valve mineralization: Review of calcification mechanisms and strategies for prevention.
    Jorge-Herrero E; Garcia Paez JM; Del Castillo-Olivares Ramos JL
    J Appl Biomater Biomech; 2005; 3(2):67-82. PubMed ID: 20799226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.